Loading…
Kidney Disease Equitable Access, Prevention, and Research Act of 2012
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
59pct
11d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2012 · fourth_quarter · Health Issues
Coverage of End Stage Renal Disease (ESRD) in Essential Health Benefits Application of premium tax credits and cost-sharing subsidies for ESRD patients in health exchanges Ensuring adequacy of networks and consumer protections for ESRD patients in the exchanges S. 2163 / H.R. 6011 - To promote equitable access, prevention and research for kidney disease patients
Client expense: $10,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
2012 · third_quarter · Health Issues
S.2163, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 H.R.6011, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules; Treasury Department outreach related to ACA implementation; implementation of Medicare Improvement for Patients and Providers Act (MIPPA)
Client expense: Not reported · Firm income: $200,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2012 · third_quarter · Medicare/Medicaid
S.2163, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 H.R.6011, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules; Treasury Department outreach related to ACA implementation; implementation of Medicare Improvement for Patients and Providers Act (MIPPA)
Client expense: Not reported · Firm income: $200,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2012 · third_quarter · Medicare/Medicaid
S.2163, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 H.R.6011, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules; implementation of Medicare Improvement for Patients and Providers Act (MIPPA)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
S.2163, Kidney Disease Equitable Access, Prevention, and Research Act of 2012; H.R.6011, Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules; implementation of Medicare Improvement for Patients and Providers Act (MIPPA)
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Health Issues
Coverage of End Stage Renal Disease (ESRD) in Essential Health Benefits Application of premium tax credits and cost-sharing subsidies for ESRD patients in health exchanges Ensuring adequacy of networks and consumer protections for ESRD patients in the exchanges S. 2163 / H.R. 6011 - To promote equitable access, prevention and research for kidney disease patients
Client expense: $20,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2012 · second_quarter · Health Issues
S.2163 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 H.R.6011 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules
Client expense: Not reported · Firm income: $200,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2012 · second_quarter · Medicare/Medicaid
S.2163 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 H.R.6011 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules
Client expense: Not reported · Firm income: $200,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2012 · second_quarter · Medicare/Medicaid
S.2163 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 H.R.6011 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
S.2163 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 H.R.6011 : Kidney Disease Equitable Access, Prevention, and Research Act of 2012 and implementation of new health exchange rules
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Health Issues
Coverage of ESRD in Essential Health Benefits Application of tax credits and cost-sharing subisidies for ESRD patients in the exchange Ensuring adequacy of networks and consumer protections in exchanges S. 2163 / H.R. 6011 - Kidney Disease Equitable Acess, Prevention and Research Act
Client expense: $25,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office